Egg phospholipids

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Egg phospholipids is a compound used as a calorie source in parenteral nutrition.

Generic Name
Egg phospholipids
DrugBank Accession Number
DB14233
Background

Egg phospholipids are primarily a mixture of naturally occurring phospholipids which are isolated from the egg yolk. Egg phospholipids are available as an intravenous fat emulsion indicated as a source of calories for patients requiring parenteral nutrition.

Type
Biotech
Groups
Approved, Experimental, Investigational
Synonyms
  • Egg lecithin
  • Egg lecithin component of endolipide
  • Egg oil lecithin
  • Egg oil phospholipids
  • Egg phosphatides
  • Egg phospholipid
  • Egg phospholipids
  • Egg yolk lecithin
  • Egg yolk lecithins
  • Egg yolk phosphatides
  • Egg yolk phospholipids
  • Endolipide component egg lecithin
  • Lecithins, egg yolk
  • Phospholipids egg

Pharmacology

Indication

For use as a source of calories for patients requiring parenteral nutrition.

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
10% Travamulsion Liq IVEgg phospholipids (1.2 g / 100 mL) + Soybean oil (10 g / 100 mL)LiquidIntravenousBaxter Corporation Clintec Nutrition Division1995-12-312015-08-05Canada flag
20% Travamulsion Liq IVEgg phospholipids (1.2 g / 100 mL) + Soybean oil (20 g / 100 mL)LiquidIntravenousBaxter Corporation Clintec Nutrition Division1995-12-312015-08-05Canada flag
DAILY-ONE 45 FILM TABLETEgg phospholipids (23 mg) + Ascorbic acid (90 mg) + Beta carotene (2000 IU) + Biotin (0.06 mg) + Calcium phosphate, tribasic (100 mg) + Calcium phosphate, tribasic (50 mg) + Choline bitartrate (3.9 mg) + Chromium nicotinate (0.13 mg) + Cupric sulfate (2 mg) + Cyanocobalamin (0.015 mg) + Ferrous fumarate (18 mg) + Folic acid (0.4 mg) + Inositol (3.9 mg) + Magnesium oxide (40 mg) + Manganese sulfate (3.5 mg) + Niacin (20 mg) + Pantothenic acid (20 mg) + Potassium Iodide (0.15 mg) + Potassium citrate (18 mg) + Pyridoxine hydrochloride (12 mg) + Riboflavin (10.2 mg) + Sodium selenite (0.07 mg) + Sodium molybdate (0.05 mg) + Thiamine hydrochloride (9 mg) + Vitamin A acetate (8000 IU) + Vitamin D (400 IU) + Vitamin E (60 IU) + Zinc gluconate (15 mg)Tablet, film coatedFERROSAN SAĞLIK ÜRÜN VE HİZMETLERİ A.Ş.2020-08-14Not applicableTurkey flag
INTRALIPID 20%Egg phospholipids (1.2 %) + Glycerin (2.25 %) + Soybean oil (20 %)InjectionIntravenousFRESENIUS KABI MALAYSIA SDN. BHD2020-09-08Not applicableMalaysia flag
KABIVEN EMULSION FOR INFUSIONEgg phospholipids (2.3 g/1000ml) + Alanine (4.7 g/1000ml) + Arginine (3.3 g/1000ml) + Aspartic acid (0.99 g/1000ml) + Calcium chloride dihydrate (0.29 g/1000ml) + D-glucose monohydrate (107 g/1000ml) + Glutamic acid (1.6 g/1000ml) + Glycerin (4.3 g/1000ml) + Glycine (2.3 g/1000ml) + Histidine (2 g/1000ml) + Isoleucine (1.6 g/1000ml) + Leucine (2.3 g/1000ml) + Lysine hydrochloride (3.3 g/1000ml) + Magnesium sulfate heptahydrate (0.96 g/1000ml) + Methionine (1.6 g/1000ml) + Phenylalanine (2.3 g/1000ml) + Potassium chloride (1.7 g/1000ml) + Proline (2 g/1000ml) + Serine (1.3 g/1000ml) + Sodium acetate trihydrate (2.4 g/1000ml) + Sodium glycerophosphate (1.5 g/1000ml) + Soybean oil (39 g/1000ml) + Threonine (1.6 g/1000ml) + Tryptophan (0.56 g/1000ml) + Tyrosine (0.07 g/1000ml) + Valine (2.1 g/1000ml)InjectionIntravenousFRESENIUS KABI (SINGAPORE) PTE LTD2001-09-04Not applicable
LIPOFUNDIN MCT/LCT INFUSION 20%Egg phospholipids (12 g/1000ml) + Glycerin (25 g/1000ml) + Medium-chain triglycerides (100 g/1000ml) + Soybean oil (100 g/1000ml)InjectionIntravenousB. BRAUN SINGAPORE PTE LTD1991-04-08Not applicable
LIPOFUNDIN N EMULSION FOR INFUSION 20 %Egg phospholipids (12 g/1000ml) + Glycerin (25 g/1000ml) + Soybean oil (200 g/1000ml)InjectionIntravenousB. BRAUN SINGAPORE PTE LTD2001-09-21Not applicable
Liposyn IIEgg phospholipids (1.2 g/100mL) + Safflower oil (10 g/100mL) + Soybean oil (10 g/100mL)Injection, emulsionIntravenousHospira, Inc.1984-08-272011-02-01US flag
Liposyn IIEgg phospholipids (1.2 g/100mL) + Safflower oil (5 g/100mL) + Soybean oil (5 g/100mL)Injection, emulsionIntravenousHospira, Inc.1984-08-272011-02-01US flag
Liposyn II 10%Egg phospholipids (0.9 %) + Safflower oil (5 %) + Soybean oil (5 %)EmulsionIntravenousHospira Healthcare Ulc1987-12-312014-08-01Canada flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
OMEGAVEN EMULSIYONEgg phospholipids (1.2 g) + DL-alpha-Tocopherol (0.0223 g) + Doconexent (2.265 g) + Glycerin (2.5 g) + Icosapent (2.035 g)Injection, emulsionIntravenousFRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-14Not applicableTurkey flag
PuralorEgg phospholipids (42.5 mg/1) + 1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine (5 mg/1) + 1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine (2.5 mg/1) + Acetylcysteine amide (5 mg/1) + Ascorbic acid (25 mg/1) + Cholecalciferol (100 [iU]/1) + Citric acid (1.6 mg/1) + Cobamamide (2 mg/1) + Folic acid (42.5 mg/1) + Gastric intrinsic factor (2.5 mg/1) + Magnesium L-threonate (2.5 mg/1) + Leucovorin (3 mg/1) + Levomefolic acid (0.4 mg/1) + Magnesium glycinate (1 mg/1) + Niacin (0.5 mg/1) + Pantethine (2.5 mg/1) + Papain (20 mg/1) + Riboflavin (0.5 mg/1) + Sodium citrate (0.8 mg/1) + Thiamine chloride (0.5 mg/1)Tablet, chewableOralCenturion Labs2014-01-012017-09-20US flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
1Z74184RGV
CAS number
93685-90-6

References

General References
  1. TITCK Product Information: OMEGAVEN (DL-alpha-tocopherol, doconexent, egg phospholipids, glycerin, and icosapent) injection [Link]
RxNav
349762

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentHippel Lindau Disease / Renal Cancers1
Not AvailableTerminatedPreventionHypertriglyceridemias1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
LiquidIntravenous
Tablet, film coated
InjectionIntravenous
InjectionIntravenous2.3 g/1000ml
InjectionIntravenous12 g/1000ml
EmulsionIntravenous
Injection, emulsionIntravenous
InjectionIntravenous12 g/L
CapsuleOral
Tablet, chewableOral
Prices
Not Available
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)Region
US9717852No2017-08-012033-04-08US flag

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 05, 2018 02:37 / Updated on June 22, 2021 18:16